Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Glucose transporter-1"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Glucose Transporter-1 Expression in Squamous Cell Carcinoma of the Tongue
Yoon Seok Choi, Seok Jin Kim, Dae Sik Kim, Seh Jong Park, Yong Park, Hye Jin Shin, Kwang-Yoon Jung, Seung-Kuk Baek, Bong Kyung Shin, Jung Woo Choi, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim
Cancer Res Treat. 2007;39(3):109-115.   Published online September 30, 2007
DOI: https://doi.org/10.4143/crt.2007.39.3.109
AbstractAbstract PDFPubReaderePub
Purpose

Tumor cells are known to express hypoxia-related proteins such as glucose transporter-1 (Glut-1). These hypoxia-induced changes may allow tumor cells to survive under sustained hypoxic microenvironments, and the surviving tumor cell under hypoxia may develop a more aggressive phenotype and so result in a poor prognosis.

Materials and Methods

The Glut-1 expression was analyzed by immunohistochemistry, and its association with the prognosis was assessed in 60 patients with squamous cell carcinoma of the tongue.

Results

The Glut-1 expression was diffuse with a membranous pattern, and the median percentage of Glut-1 positive tumor cells was 60% (range: 0.0~90.0%). A high Glut-1 expression (the percentage of positive tumor cells ≥ the median value, 60%) was associated with the location of primary lesion, lymph node metastasis status and disease stage (p<0.05). The expression of Glut-1 was correlated with the Ki-67 expression (r=0.406, p=0.001). Microvessel density, as represented by CD31 staining, was also correlated with the Glut-1 expression although its significance is weak (r=0.267, p=0.039). On the univariate analysis, the group with a high Glut-1 expression showed poorer overall survival than the group with a low Glut-1 expression (p<0.05). However, the Glut-1 expression failed to show any independent prognostic significance on the multivariate analysis.

Conclusion

The expression of Glut-1 may be useful for predicting the prognosis and determining the treatment strategy for the management of squamous cell carcinoma of the tongue.

Citations

Citations to this article as recorded by  
  • Study of expression of GLUT-1 in oral potentially malignant disorders and oral squamous cell carcinoma: An immuno-histochemical analysis
    Shylaja K. Attur, Anil Patel, Kailash M. Attur
    Journal of Oral and Maxillofacial Pathology.2024; 28(1): 70.     CrossRef
  • Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis
    Yanting Wang, Yuanyuan Li, Laibo Jiang, Xianyue Ren, Bin Cheng, Juan Xia
    Aging.2021; 13(5): 7284.     CrossRef
  • The Role of Glucose Transporters in Oral Squamous Cell Carcinoma
    Heinrich Botha, Camile S. Farah, Kendrick Koo, Nicola Cirillo, Michael McCullough, Rita Paolini, Antonio Celentano
    Biomolecules.2021; 11(8): 1070.     CrossRef
  • Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
    Angara Zambrano, Matías Molt, Elena Uribe, Mónica Salas
    International Journal of Molecular Sciences.2019; 20(13): 3374.     CrossRef
  • Can increased metabolic status be a grading tool for oral squamous cell carcinoma? A glucose transporter 1 immunoexpression study
    Abikshyeet Panda, Alokenath Bandyopadhyay, Gouse Mohiddin, Malvika Raghuvanshi, SanjayKumar Sahoo, Lipsa Bhuyan
    Nigerian Journal of Surgery.2019; 25(2): 203.     CrossRef
  • Plumbagin‐mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma
    S Na, J Zhang, X Zhou, A Tang, D Huang, Q Xu, D Xue, J Qiu
    Oral Diseases.2018; 24(6): 920.     CrossRef
  • Expression of GLUT-1 in oral squamous cell carcinoma in tobacco and non-tobacco users
    Neha Azad, Malti Kumari Maurya, Meenakshi Kar, Madhu Mati Goel, Ajay Kumar Singh, Mala Sagar, Divya Mehrotra, Vijay Kumar
    Journal of Oral Biology and Craniofacial Research.2016; 6(1): 25.     CrossRef
  • Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers
    Marcelo Gadelha Vasconcelos, Rodrigo Gadelha Vasconcelos, Denise Hélen Imaculada Pereira de Oliveira, Edilmar de Moura Santos, Leão Pereira Pinto, Éricka Janine Dantas da Silveira, Lélia Maria Guedes Queiroz
    Journal of Oral and Maxillofacial Surgery.2015; 73(9): 1753.     CrossRef
  • Expression of glucose transporters in cancers
    Leszek Szablewski
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2013; 1835(2): 164.     CrossRef
  • T-Type Ca2+Channels in Normal and Abnormal Brain Functions
    Eunji Cheong, Hee-Sup Shin
    Physiological Reviews.2013; 93(3): 961.     CrossRef
  • Glucose uptake mediated by glucose transporter 1 is essential for early tooth morphogenesis and size determination of murine molars
    Hiroko Ida-Yonemochi, Mitsushiro Nakatomi, Hidemitsu Harada, Hiroki Takata, Otto Baba, Hayato Ohshima
    Developmental Biology.2012; 363(1): 52.     CrossRef
  • Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary
    Ja Seung Koo, Haeryoung Kim
    Tumor Biology.2011; 32(5): 893.     CrossRef
  • 10,522 View
  • 57 Download
  • 12 Crossref
Close layer
Correlation of GLUT-1 Expression and F-18-FDG Uptake on Positron Emission Tomography in Breast Carcinoma
Gi Jeong Cheon, June Key Chung, Bo Kwang Kim, Yong Jin Lee, Dong Young Noh, Ja June Jang, Jeong Seok Yeo, Jae Min Jeong, Dong Soo Lee, Myung Chul Lee
J Korean Cancer Assoc. 2000;32(6):1067-1074.
AbstractAbstract PDF
PURPOSE
Fluorine-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) has been proven to be useful in the detection of breast cancer. However, the degree of FDG uptake was variable. In this study, we evaluated the relationship between glucose transporter-1 (GLUT-1) expression with the FDG uptake in patients with breast cancer.
MATERIALS AND METHODS
15 patients with proven breast cancer underwent F-18-FDG PET. After surgical resection, anti-GLUT-1 immunohistochemical staining was performed in tumor tissues to measure the GLUT-1 expression. We evaluated the correlation between semi-quantitative FDG uptake by standardized uptake value (SUV) and GLUT-1 expression.
RESULTS
In total 15 patients, there was no significant correlation between SUV and GLUT-1 expression. We separated the patients into two groups according to the tumor size. In the group of large tumor (short diameter > or =2 cm), there was no significant correlation. However, in the group of small tumor (short diameter <2 cm), there was a significant correlation between the FDG uptake and GLUT-1 expression (rho=0.812, p=0.047).
CONCLUSION
GLUT-1 expression can influence the FDG uptake in the small breast cancers. For large breast cancers, other factors as well as GLUT-1 expression may influence the FDG uptake.
  • 2,686 View
  • 18 Download
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP